PRKCB and neoplasm: Analysis of single-cell transcriptomic data from the TISCH2 database (GSE117570) revealed that PRKCB is highly expressed in B cells, CD8+ effector T cells (CD8 Teff), and NK cells, while its expression is low in malignant tumor cells (Figures 5A–C).